Pro-inflammatory and pro-resolving mechanisms in the immunopathology of arteriovenous fistula maturation

References

• Pisoni RL, Zepel L, Port FK, et al. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Diseases. 2015;65(6):905–915.
   PubMed Web of Science ®Google Scholar
• Lok CE, Sontrop JM, Tomlinson G, et al. Cumulative patency of contemporary fistulas versus grafts (2000–2010). Clin J Am Soc Nephrol. 2013;8(5):810–818.
   PubMed Web of Science ®Google Scholar
• Huijbregts HJ, Bots ML, Wittens CH, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol. 2008;3(3):714–719.
   PubMed Web of Science ®Google Scholar
• Dixon B. Why dont fistulas mature? Kidney Int. 2006;70(8):1413–1422.
   PubMed Web of Science ®Google Scholar
• Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: upper-arm native arteriovenous fistula. Am J Kidney Diseases. 2002;39(1):92–101.
   PubMed Web of Science ®Google Scholar
• Lazarides MK, Georgiadis GS, Antoniou GA, et al. A meta-analysis of dialysis access outcome in elderly patients. J Vasc Surg. 2007;45(2):420–426.e2.
   PubMed Web of Science ®Google Scholar
• Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. JAMA. 2008;299(18):2164.
   PubMed Web of Science ®Google Scholar
• Siddiqui MA, Ashraff S, Carline T. Maturation of arteriovenous fistula: analysis of key factors. Kidney Res Clin Pract. 2017;36(4):318–328.
   PubMed Web of Science ®Google Scholar
• Lok CE, Oliver MJ, Su J, et al. Arteriovenous fistula outcomes in the era of the elderly dialysis population. Kidney Int. 2005;67(6):2462–2469.
   PubMed Web of Science ®Google Scholar
• Chan C, Katz S. Prognostic factors for arteriovenous fistula maturation. Ann Vasc Surg. 2017;43:48.
   Google Scholar
• Lauvao LS, Ihnat DM, Goshima KR, et al. Vein diameter is the major predictor of fistula maturation. J Vasc Surg. 2009;49(6):1499–1504.
   PubMed Web of Science ®Google Scholar
• Wasse H, Huang R, Naqvi N, et al. Inflammation, oxidation and venous neointimal hyperplasia precede vascular injury from AVF creation in CKD patients. J Vasc Access. 2011;13(2):168–174.
   Web of Science ®Google Scholar
• Simone S, Loverre A, Cariello M, et al. Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis. J Nephrol. 2014;27(5):555–562.
   PubMed Web of Science ®Google Scholar
• Dixon B, Beck G, Vazquez M. Effect of dipyridamole plus aspirin on hemodialysis graft patency. J Vasc Surg. 2009;50(3):701.
   Google Scholar
• Hammes M. Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients. Biomed Res Int. 2015;2015:1–7.
   Google Scholar
• Li L, Terry CM, Blumenthal DK, et al. Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model. Nephrol Dialysis Transplantation. 2007;22(11):3139–3146.
   PubMed Web of Science ®Google Scholar
• Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190(3):300–309.
   PubMed Web of Science ®Google Scholar
• Rekhter M, Nicholls S, Ferguson M, et al. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb J Vasc Biol. 1993;13(4):609–617.
   PubMedGoogle Scholar
• Owen WF. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54(2):627–636.
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Diseases. 1997;29(5):658–668.
   PubMed Web of Science ®Google Scholar
• Gunnell J, Yeun JY, Depner TA, et al. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Diseases. 1999;33(1):63–72.
   PubMed Web of Science ®Google Scholar
• Kaygin MA, Halici U, Aydin A, et al. The relationship between arteriovenous fistula success and inflammation. Ren Fail. 2013;35(8):1085–1088. .
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Don BR. Factors that affect albumin concentration in dialysis patients and their relationship to vascular disease. Kidney Int. 2003;63:S94-S97.
   Web of Science ®Google Scholar
• Kronenberg F. Homocysteine, lipoprotein(a) and fibrinogen. Curr Opin Nephrol Hypertens. 1998;7(3):271–278.
   PubMed Web of Science ®Google Scholar
• Wali MA, Eid RA, Dewan M, et al. Pre-existing histopathological changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction. Ann Thorac Cardiovasc Surg. 2006;12(5):341–348.
   PubMedGoogle Scholar
• Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105(5):546–549.
   PubMed Web of Science ®Google Scholar
• Chang C-J, Ko Y-S, Ko P-J, et al. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int. 2005;68(3):1312–1319. .
   PubMed Web of Science ®Google Scholar
• Wang X, Khalil RA. Matrix metalloproteinases, vascular remodeling, and vascular disease. Adv Pharmacol Vasc Pharmacol. 2018;241–330. DOI:10.1016/bs.apha.2017.08.002
   Google Scholar
• Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Investig. 1994;94(6):2493–2503.
   PubMed Web of Science ®Google Scholar
• Ikeda U, Ikeda M, Oohara T, et al. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol Heart Circ Physiol. 1991;260(5):H1713-H1717.
   Google Scholar
• Oguchi S, Dimayuga P, Zhu J, et al. Monoclonal antibody against vascular cell adhesion molecule-1 Inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol. 2000;20(7):1729–1736.
   PubMed Web of Science ®Google Scholar
• Stracke S, Konner K, Köstlin I, et al. Increased expression of TGF-β1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas. Kidney Int. 2002;61(3):1011–1019.
   PubMed Web of Science ®Google Scholar
• Yuan S-M, Wang Y-Q, Shen Y, et al. Transforming growth factor-β in graft vessels: histology and immunohistochemistry. Clinics. 2011;66(5):895–901.
   PubMed Web of Science ®Google Scholar
• Kanzaki T, Tamura K, Takahashi K, et al. In vivo effect of TGF-β1. Arterioscler Thromb Vasc Biol. 1995;15(11):1951–1957.
   PubMed Web of Science ®Google Scholar
• Wilson VJ, Ward JR, Burnand KG, et al. Upregulation of IGF-I and collagen I mRNA in human atherosclerotic tissue is not accompanied by changes in type 1 IGF receptor or collagen III mRNA. Coron Artery Dis. 1996;7(8):569–572.
   PubMed Web of Science ®Google Scholar
• Sharma G, Kuppler C, He Y, et al. Local adipose-associated mediators and adaptations following arteriovenous fistula creation. Kidney Int Rep. 2018;3(4):970–978. .
   PubMed Web of Science ®Google Scholar
• Selzman CH, Miller SA, Zimmerman MA, et al. Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation. Am J Physiol Heart Circ Physiol. 2002;283(4):H1455-H1461.
   PubMed Web of Science ®Google Scholar
• Mauro CR, Ding K, Xue H, et al. Adipose phenotype predicts early human autogenous arteriovenous hemodialysis remodeling. J Vasc Surg. 2016;63(1). DOI:10.1016/j.jvs.2014.06.110
   Web of Science ®Google Scholar
• Martinez L, Tabbara M, Duque JC, et al. Transcriptomics of human arteriovenous fistula failure: genes associated with nonmaturation. Am J Kidney Diseases. 2019 Feb 27. pii: S0272-6386(19)30045-9. doi: 10.1053/j.ajkd.2018.12.035. [Epub ahead of print].
   Google Scholar
• Liang A, Wang Y, Han G, et al. Chronic kidney disease accelerates endothelial barrier dysfunction in a mouse model of an arteriovenous fistula. Am J Physiol Renal Physiol. 2013;304(12):F1413-F1420.
   PubMed Web of Science ®Google Scholar
• Asare Y, Schmitt M, Bernhagen J. The vascular biology of macrophage migration inhibitory factor (MIF). Thromb Haemost. 2013;109(03):391–398.
   PubMedGoogle Scholar
• Brahmbhatt A, Remuzzi A, Franzoni M, et al. The molecular mechanisms of hemodialysis vascular access failure. Kidney Int. 2016;89(2):303–316.
   PubMed Web of Science ®Google Scholar
• Boring L, Gosling J, Cleary M, et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394(6696):894–897.
   PubMed Web of Science ®Google Scholar
• Gerszten RE, Garcia-Zepeda EA, Lim Y-C, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature. 1999;398(6729):718–723.
   PubMed Web of Science ®Google Scholar
• Juncos JP, Grande JP, Kang L, et al. MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol. 2011;22(1):43–48.
   PubMed Web of Science ®Google Scholar
• Wan J, Lata C, Santilli A, et al. Supplemental oxygen reverses hypoxia-induced smooth muscle cell proliferation by modulating HIF-alpha and VEGF levels in a rabbit arteriovenous fistula model. Ann Vasc Surg. 2014;28(3):725–736.
   PubMed Web of Science ®Google Scholar
• Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. BMB Rep. 2006;39(5):469–478.
   Google Scholar
• Wang H, Keiser JA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells. Circ Res. 1998;83(8):832–840.
   PubMed Web of Science ®Google Scholar
• Croatt AJ, Grande JP, Hernandez MC, et al. Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME. Am J Pathol. 2010;176(5):2530–2541.
   PubMed Web of Science ®Google Scholar
• Kopp JB, Factor VM, Mozes M, et al. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest. 1996;74(6):991–1003.
   PubMed Web of Science ®Google Scholar
• Samarakoon R, Overstreet JM, Higgins SP, et al. TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res. 2011;347(1):117–128.
   PubMed Web of Science ®Google Scholar
• Selzman CH, Shames BD, Reznikov LL, et al. Liposomal delivery of purified inhibitory-κBα inhibits tumor necrosis factor-α–induced human vascular smooth muscle proliferation. Circ Res. 1999;84(8):867–875.
   PubMed Web of Science ®Google Scholar
• Zhang L, Peppel K, Brian L, et al. Vein graft neointimal hyperplasia is exacerbated by tumor necrosis factor receptor-1 signaling in graft-intrinsic cells. Arterioscler Thromb Vasc Biol. 2004;24(12):2277–2283.
   PubMed Web of Science ®Google Scholar
• Antwerp DJV, Martin SJ, Verma IM, et al. Inhibition of TNF-induced apoptosis by NF-κB. Trends Cell Biol. 1998;8(3):107–111.
   PubMed Web of Science ®Google Scholar
• Schulze-Osthoff K, Ferrari D, Los M, et al. Apoptosis signaling by death receptors. Eur J Biochem. 1998;254(3):439–459.
   PubMedGoogle Scholar
• Zimmerman MA, Selzman CH, Reznikov LL, et al. Lack of TNF-α attenuates intimal hyperplasia after mouse carotid artery injury. Am J Physiol Regul Integr Comp Physiol. 2002;283(2). DOI:10.1152/ajpregu.00033.2002
   Web of Science ®Google Scholar
• Zimmerman MA, Reznikov LL, Sorensen AC, et al. Relative contribution of the TNF-α receptors to murine intimal hyperplasia. Am J Physiol Regul Integr Comp Physiol. 2003;284(5). DOI:10.1152/ajpregu.00434.2002
   PubMed Web of Science ®Google Scholar
• Bai X, Xi J, Bi Y, et al. TNF-α promotes survival and migration of MSCs under oxidative stress via NF-κB pathway to attenuate intimal hyperplasia in vein grafts. J Cell Mol Med. 2017;21(9):2077–2091.
   PubMed Web of Science ®Google Scholar
• Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92–101.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Komshian S, Sansbury BE, et al. Biosynthesis of proresolving lipid mediators by vascular cells and tissues. FASEB J. 2017;31(8):3393–3402.
   PubMed Web of Science ®Google Scholar
• Rozowsky J, Staton K, O‘Malley K, et al. Distinct lipid mediator profile associated with arteriovenous fistula maturation. Academic Surgical Congress Abstracts. 2018. Available from: https://www.asc-abstracts.org/abs2018/61-03-distinct-lipid-mediator-profile-associated-with-arteriovenous-fistula-maturation/.
   Google Scholar
• Irish AB, Viecelli AK, Hawley CM, et al. Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis. JAMA Intern Med. 2017;177(2):184.
   PubMed Web of Science ®Google Scholar
• Satish M, Agrawal DK. Pro-resolving lipid mediators in the resolution of neointimal hyperplasia pathogenesis in atherosclerotic diseases. Expert Rev Cardiovasc Ther. 2018;1–8. DOI:10.1080/14779072.2019.1563483
   Web of Science ®Google Scholar
• Sansbury BE, Spite M. Resolution of acute inflammation and the role of resolvins in immunity, thrombosis, and vascular biology. Circ Res. 2016;119(1):113–130.
   PubMed Web of Science ®Google Scholar
• Bashar K, Zafar A, Ahmed K, et al. Can a neutrophil–lymphocyte ratio derived from preoperative blood tests predict arteriovenous fistula maturation? Ann Vasc Surg. 2016;35:60–67..
   PubMed Web of Science ®Google Scholar
• Yilmaz H, Bozkurt A, Cakmak M, et al. Relationship between late arteriovenous fistula (AVF) stenosis and neutrophil–lymphocyte ratio (NLR) in chronic hemodialysis patients. Ren Fail. 2014;36(9):1390–1394.
   PubMed Web of Science ®Google Scholar
• Tong X, Hou X, Wason C, et al. Smooth muscle nitric oxide responsiveness and clinical maturation of hemodialysis arteriovenous fistulae. Am J Pathol. 2017;187(9):2095–2101. .
   PubMed Web of Science ®Google Scholar
• Kapadia MR, Chow LW, Tsihlis ND, et al. Nitric oxide and nanotechnology: a novel approach to inhibit neointimal hyperplasia. J Vasc Surg. 2008;47(1):173–182.
   PubMed Web of Science ®Google Scholar
• Tsihlis ND, Kapadia MR, Vavra AK, et al. Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature. J Vasc Surg. 2013;58(1):179–186.
   PubMed Web of Science ®Google Scholar
• Santana J, Hashimoto T, Foster T, et al. eNOS mediates arteriovenous fistula maturation. J Am Coll Surg. 2016;223(4):S163–S164. Available from: https://www.journalacs.org/article/S1072-7515(16)30272-1/fulltext
   Web of Science ®Google Scholar
• Sugimoto M, Yamanouchi D, Komori K. Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway. Surg Today. 2009;39(6):459–465.
   PubMed Web of Science ®Google Scholar
• Rikitake Y, Liao JK. ROCKs as therapeutic targets in cardiovascular diseases. Expert Rev Cardiovasc Ther. 2005;3(3):441–451.
   PubMedGoogle Scholar
• Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002–2012.
   PubMed Web of Science ®Google Scholar
• Furuyama T, Komori K, Shimokawa H, et al. Long-term inhibition of Rho kinase suppresses intimal thickening in autologous vein grafts in rabbits. J Vasc Surg. 2006;43(6):1249–1256.
   PubMed Web of Science ®Google Scholar
• Laufs U, Fata VL, Plutzky J, et al. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation. 1998;97(12):1129–1135.
   PubMed Web of Science ®Google Scholar
• Leung T, Manser E, Tan L, et al. A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem. 1995;270(49):29051–29054.
   PubMed Web of Science ®Google Scholar
• Cui J, Jhajj HS, Kessinger CW, et al. Statin therapy decreases vascular inflammation and prolongs patency in murine arteriovenous fistula. Arterioscler Thromb Vasc Biol. 2017;37:A529. [cited 2019 Jan 12]. Available from: https://www.ahajournals.org/doi/abs/10.1161/atvb.37.suppl_1.529
   Web of Science ®Google Scholar
• Bezhaeva T, Wong C, Vries MRD, et al. Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure. Sci Rep. 2017;7(1). DOI:10.1038/s41598-017-10108-4.
   Google Scholar
• Mantovani A, Biswas SK, Galdiero MR, et al. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2012;229(2):176–185.
   PubMed Web of Science ®Google Scholar
• Jetten N, Verbruggen S, Gijbels MJ, et al. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo. Angiogenesis. 2013;17(1):109–118.
   PubMed Web of Science ®Google Scholar
• Kuwahara G, Hashimoto T, Tsuneki M, et al. CD44 promotes inflammation and extracellular matrix production during arteriovenous fistula maturation. Arterioscler Thromb Vasc Biol. 2017;37(6):1147–1156.
   PubMed Web of Science ®Google Scholar
• Wong C, Bezhaeva T, Rothuizen TC, et al. Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model. Sci Rep. 2016;6(1). DOI:10.1038/srep30439.
   Google Scholar